Peer review reports
From: Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer
Original Submission | ||
---|---|---|
1 Nov 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
18 Dec 2022 | Reviewed | Reviewer Report - Eman S. El-shafey |
26 Dec 2022 | Reviewed | Reviewer Report |
12 Jan 2023 | Author responded | Author comments - Jieqing Li |
Resubmission - Version 3 | ||
12 Jan 2023 | Submitted | Manuscript version 3 |
7 Feb 2023 | Author responded | Author comments - Jieqing Li |
Resubmission - Version 4 | ||
7 Feb 2023 | Submitted | Manuscript version 4 |
9 Feb 2023 | Author responded | Author comments - Jieqing Li |
Resubmission - Version 5 | ||
9 Feb 2023 | Submitted | Manuscript version 5 |
10 Feb 2023 | Author responded | Author comments - Jieqing Li |
Resubmission - Version 6 | ||
10 Feb 2023 | Submitted | Manuscript version 6 |
23 Feb 2023 | Reviewed | Reviewer Report - Eman S. El-shafey |
17 Mar 2023 | Reviewed | Reviewer Report |
22 Mar 2023 | Author responded | Author comments - Jieqing Li |
Resubmission - Version 7 | ||
22 Mar 2023 | Submitted | Manuscript version 7 |
Publishing | ||
27 Mar 2023 | Editorially accepted | |
17 Apr 2023 | Article published | 10.1186/s12885-023-10774-w |